Goldman Sachs Knock-Out CHKP/ DE000GJ08K86 /
2024-09-02 9:57:42 AM | Chg.-0.01 | Bid10:00:26 PM | Ask10:00:26 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
2.30EUR | -0.43% | - Bid Size: - |
- Ask Size: - |
Check Point Software... | 166.6987 USD | 2078-12-31 | Call |
GlobeNewswire
08-14
Molecular Templates, Inc. Reports Second Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
08-14
Anaptys Announces Pricing of $100 Million Underwritten Registered Direct Offering
GlobeNewswire
08-13
Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
08-13
Replimune Announces First Patient Dosed in IGNYTE-3 Clinical Trial in Advanced Melanoma
GlobeNewswire
08-13
PDS Biotech Provides Business Update and Reports Second Quarter 2024 Financial Results
GlobeNewswire
08-13
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
GlobeNewswire
08-12
Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024...
GlobeNewswire
08-12
Altamira Therapeutics Announces Significant Enhancement of Immune Checkpoint Inhibition Therapy in C...
GlobeNewswire
08-12
Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
GlobeNewswire
08-08
ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08-08
Bioatla Reports Second Quarter 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
08-08
PDS Biotech Announces Abstract Accepted for Oral Presentation at 2024 ASTRO Annual Meeting
GlobeNewswire
08-08
Werewolf Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08-06
Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire
08-01
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights